Form D · Venture Capital Fund
4Bio Ventures III LP
London, X0 · CIK 0001958641
Offering snapshot reported Sep 18, 2024 · SEC filing
- Reported sold
- $86.6M Offering amount: $200M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Dec 22, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2024 | Amendment | $86,633,333 | No comparison | 21 | SEC filing |
| Dec 19, 2022 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $258K
- Form D file number
- 021-467901
Source: Form D, filed Sep 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrey Kozlov | Promoter |
| Dmitry Kuzmin | Promoter |
| Kyrylo "Kieran" Mudryy | Promoter |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
48 Warwick Street
London, X0, W1B 5AW
London, X0, W1B 5AW